People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HCW Biologics Inc. | — | Biotechnology | Series A | $15.6M | $30.1M | 2024 |
Rebecca C Byam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rebecca C Byam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rick S. Greene | 1 | 2 |
| Peter C. Rhode | 1 | 2 |
| Gary M. Winer | 1 | 2 |
| Hing C. Wong | 1 | 2 |
| Peter C Sun | 1 | 1 |
| Fred M. Middleton | 1 | 1 |
| Rebecca M. Byam | 1 | 1 |
| Peter M. Rhode | 1 | 1 |
| Nicole M. Valdivieso | 1 | 1 |
| Lee C Flowers | 1 | 1 |
| Lisa M. Giles | 1 | 1 |
| Scott T. Garrett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.